Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Alyssum Therapeutics

HQ: Cambridge, MA source · alyssumtx.com ↗

Clinical Phase 2

Keywords: oncology small molecule

Location: Cambridge, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

Feb 13, 2024 Trial start Phase 1/Phase 2: Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Soli source ↗

Upcoming milestones

2026-12 (ESTIMATED) · Phase 1/Phase 2 · Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors · NCT06234098

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT06234098	Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors	Phase 1/Phase 2	Recruiting	Feb 13, 2024	2026-12 (estimated)